Skip to content

Clinical trials

Nasopharyngeal Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Neoplasms Country / region: Singapore Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20154
20161
20172
20192
20201
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status3
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore6
National Cancer Centre, Singapore4
Novartis Pharmaceuticals2
Celgene1
Cullinan Therapeutics Inc.1
National Cancer Institute (NCI)1
Tessa Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Neoplasms16
Nasopharyngeal Carcinoma9
Epstein-Barr Virus Infections4
Head and Neck Neoplasms3
Colorectal Neoplasms2
Neoplasms2
Recurrence2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.